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Abstract: Exposure to different substances in an occupational environment is of utmost 
concern to global agencies such as the World Health Organization and the International 
Labour Organization. Interest in improving work health conditions, particularly of those 
employees exposed to noxious chemicals, has increased considerably and has stimulated 
the search for new, more specific and selective tests. Recently, the field of molecular 
biology has been indicated as an alternative technique for monitoring personnel while 
evaluating work-related pathologies. Originally, occupational exposure to environmental 
toxicants was assessed using biochemical techniques to determine the presence of higher 
concentrations of toxic compounds in blood, urine, or other fluids or tissues; results were 
used to evaluate potential health risk. However, this approach only estimates the presence 
of a noxious chemical and its effects, but does not prevent or diminish the risk. Molecular 
biology methods have become very useful in occupational medicine to provide more 
accurate and opportune diagnostics. In this review, we discuss the role of the following 
common techniques: (1) Use of cell cultures; (2) evaluation of gene expression; (3) the 
“omic” sciences (genomics, transcriptomics, proteomics and metabolomics) and   
(4) bioinformatics. We suggest that molecular biology has many applications in 
occupational health where the data can be applied to general environmental conditions. 
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1. Introduction 
In everyday and occupational environments there are ubiquitous noxious chemicals that can be 
hazardous to human and wildlife health. Recently, molecular biology techniques have received greater 
attention for their potential to contribute to determining the presence of toxic substances in the 
environment that may be detrimental to health. Accurate human exposure studies require sensitive 
methods capable of evaluating dose-response relationships, particularly in cases of low level exposure 
to noxious agents. Here we describe some of the most common tools used in molecular biology that 
can be applied to evaluate the effects of chemical exposure in occupational settings. These tools are: 
(1) use of cell culture; (2) evaluation of gene expression; (3) “omic” techniques and (4) bioinformatics 
(Figure 1). Furthermore, we discuss applications of molecular biology techniques for biomonitoring 
the effects of chemical exposure on human health. Recently, the use of new molecular biomarkers has 
changed the “classical” biochemical or chemical approach of evaluating damage after chemical 
exposure. Biomarkers or biological indicators are measurable changes at the physiological, 
biochemical or morphological level in the affected organisms after toxic exposure. These biomarkers 
are used to detect exposure, determine the biological consequences of the exposure, and to evaluate 
initial or intermediate stages of pathological processes, identifying individuals that may be sensitive to 
specific chemicals. These molecules are then classified as exposure, effect or susceptibility 
biomarkers, respectively. Therefore, the purpose of developing new biomarkers is to estimate the 
relationship between environmental or occupational chemical exposures and their subsequent effects in 
individuals or open populations. 
2. Cell Cultures 
In molecular biology, cell culture techniques are an invaluable tool for analyzing physiological and 
molecular processes. Cell culture is useful for evaluating chemical damage and to establish 
cytotoxicity. Cell culture offers several advantages over animal studies. For instance, cell cultures are 
easy to handle and to keep under a controlled environment in an incubator. In addition, cell cultures 
allow for testing different compounds simultaneously and screening for chemical toxicity can be 
performed at a lower cost than in animal models.  
The use of cell culture systems in toxicology has gained wide acceptance in cell-specific and 
metabolic studies. There are several models frequently used in toxicology including: primary cell 
cultures, immortalized cell lines, stem cells, and 3D cultures [1]. 
2.1. Primary Cell Culture 
Several recent studies have used cells derived from tissues and organs to test their response to 
chemicals. The enormous advantage of primary cell culture is the direct evaluation of cytotoxicity and 
related mechanisms in normal cells. Hepatocytes are the most commonly used primary culture in 
toxicology. For example, human hepatocytes have been used to show the heterogeneity of CYP 
expression in the human liver [2]. However, the in vitro phenotypic instability of these cells, the 
irregular availability of fresh human liver and the high batch-to-batch variability of hepatocyte 
preparations obtained from donors complicate their use in routine testing [3]. In a recent study lung Int. J. Mol. Sci. 2010, 11                 
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derived cells were used to evaluate the expression of CYP isoforms following exposure to PAHs or 
nitrosamines. Expression levels of these enzymes were then used as effect biomarkers [4]. In another 
study the relevance for occupational health risk assessment of engineered nanoparticles in lung toxicity 
is addressed. In this study, primary cells, such as epithelial and alveolar macrophages, are used to 
evaluate cytotoxicity by measuring cytokine levels [5]. Primary cells such as lymphocytes are useful to 
evaluate toxicity of carcinogenic compounds like benzene [6]. 
Figure 1. The role of molecular biology in chemical exposure analysis. A representative 
scheme shows two in vitro study approaches for specific genes or for gene groups. 
 
2.2. Cell Lines 
Various cell models have been fully characterized and collections can be obtained from research 
organizations like the American Tissue and Cell Collection (ATCC). Here representative cell lines for 
each organ or tissue can be collected for specific purposes, making it possible to evaluate the 
metabolic or genetic effects of a chemical on specific types of cells. Another advantage of these 
cultures is that they can be engineered at specific genes sites that affect certain molecular processes. 
For instance, hepatoma derived cells engineered to contain the luciferase gene respond to dioxin 
stimulus. These cells are called CALUX and are also useful for evaluating environmental impact [7]. 
Another example is the use of immortalized cell lines like A549 (a lung cell line) to evaluate toxicity 
to aromatic compounds [8]. An additional study suggests that immortalized keratinocytes lines Int. J. Mol. Sci. 2010, 11                 
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(RHEK-1, HaCaT, and NM1) can be used to evaluate toxicity of chemicals such as lead, cadmium or 
arsenic [9]. Moreover, the role of transcriptional regulation and cell signaling in drug-exposed cells 
offers new study opportunities [10]. As mentioned before, engineered cell cultures are useful to test the 
role of exposure to a chemical agent in the over-expression or down-regulation of certain proteins. Cell 
cultures could be engineered by plasmid or siRNA transfection, virus transduction or biobalistics. 
Genetic engineering of cells is important for analyzing the genotoxicity associated with specific 
xenobiotic-metabolizing enzymes and it is useful for elucidating metabolic activation and inactivation 
processes. In a recent work, a cell line derived from Chinese hamster V79 was modified to express 
both human cytochrome P450 (CYP) 2E1 and human sulfotransferase (SULT). However, although 
these cells activate various important pro-genotoxicants, they have been observed to elevate 
spontaneous gene mutation frequencies [11]. The use of the V79 cell line in the study of cytochrome 
P450 using siRNA technology is another example of the importance of cell lines in toxicology [12]. 
2.3. Stem Cells 
The ability to proliferate without limits and easily differentiate into different cell types are 
advantages of stem cell cultures over other systems (i.e., primary cells). As a result of these advantages 
stem cell cultures have generated great interest as potential tools for toxicological screening. Stem cell 
culture systems help to evaluate differentiation or transdifferentation of stem cells to non-related 
tissues in the presence of teratogenic chemicals [1]. In other cases, these cells are induced to 
differentiate into hepatocytes or cardiomyocytes to test chemical agents [13]. However, the use of stem 
cells from embryonic tissue, human embryonic stem cells (hESC), remains controversial. Recently 
new perspectives have been opened by the use of induced pluripotent stem cells (iPSC), generated by 
the virus-mediated expression of only four genes and shown to demonstrate characteristics similar to 
those of hESC [14]. Phthalates are synthetic ubiquitous compounds distributed into the environment. 
Humans are continually exposed to phthalates due to their use in plastics and other common consumer 
products. It is worth mentioning that, due to their hormone profile, women are particularly susceptible 
and have a unique exposure profile to phthalates, raising concern for potential health hazards. In a 
recent study, stem cells were used to analyze cytotoxicity and gene expression in phthalate treated 
cells. Results from this study are useful to understand potential mechanisms of toxicity in human 
embryos [15]. In another study, researchers used mouse embryonic stem cells to evaluate both the 
neuropathy target esterase as a biomarker of embryotoxicity processes and its role in differentiation [16]. 
2.4. Three Dimensional-Cultures 
In three-dimensional (3D) cultures, cells are seeded in a protein matrix. This matrix allows a well 
defined geometry and establishes a similar environment to that of a tissue (an in vivo-like niche), while 
the 3D culture promotes cellular interaction between cells and the matrix. Several polymers useful for 
matrix constitution include: agarose, collagen, gelatin and matrigel [17]. Another advantage of this 
model is the possibility of establishing a co-culture or promoting differentiation. In fact, a microarray 
using 3D culture has been successfully employed to evaluate toxicity of chemical compounds by 
analyzing cytochrome P450 induction [18]. Modeling 3D cultures is a useful tool to improve the 
predictive value of cell-based assays for safety and risk assessment studies [19]. In a recent study, Int. J. Mol. Sci. 2010, 11                 
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HepG2 cells cultured in a 3D matrix were observed to exhibit an increase in hepatocyte-specific 
functions, including drug-metabolizing enzyme activities, making this model suitable for evaluating 
toxicity in vitro [20]. Furthermore, 3D cultures have been established to test cellular and molecular 
effects on occupationally-exposed individuals [21]. Finally, it has recently been suggested that 3D 
cultures can reduce the cost of evaluating the toxic potential of new drugs or xenobiotics [22], and the 
toxicity of nanoparticles [23]. 
3. Evaluation of Gene Expression 
By using molecular biology, we can evaluate gene expression by measuring mRNA or protein 
levels. Several routine techniques, such as polymerase chain reaction (PCR), Enzyme-Linked 
ImmunoSorbent Assay (ELISA) or microarrays have an extensive application in chemical exposure 
monitoring. Furthermore, some of these techniques can be performed at a lower cost and in less time in 
comparison to other classical techniques. In fact, the use of real time PCR has had an enormous impact 
in toxicology due its accuracy and versatility. Recently, occupational toluene [24] exposure was 
evaluated using CYP2E1 expression as a biomarker by real time PCR. ELISA has become another 
useful tool for rapidly detecting and quantifying proteins in multiple samples. Finally, microarrays can 
detect expression of several genes simultaneously and in specific conditions. Recently, microarray 
technology has been used to evaluate gene expression of four toxic components: oxythioquinox 
(a quinoxaline pesticide); malathion (an organophosphate pesticide); di-n-butyl phthalate (a chemical 
commonly found in personal care and cosmetic items); and benzo[a]pyrene (BaP, an environmental 
and occupational carcinogen). The study found that exposure to any of these chemicals produced an 
increased expression of metabolic enzymes or genes related with fertility. In particular, BaP altered 
expression of two cytochrome P450 isoforms [25]. 
3.1. qRT PCR 
Quantitative analysis of changes in molecular targets plays an important role in addressing 
scientific questions in molecular toxicology and epidemiology, and results are used in human risk 
assessment. One of the emerging technologies used to analyze these molecular targets is quantitative 
real-time polymerase chain reaction (qRT PCR). Three applications of qRT PCR for genetic and 
molecular toxicology are: quantification of gene expression, detection of genetic polymorphisms, and 
quantification of chromosomal DNA deletions [26,27]. Gene expression analysis has become an 
approach to identify biomarkers and understand mechanisms of toxicity. For example, Cyclin D1 
expression is an effective biomarker for evaluating cell proliferation in response to a particular toxic 
agent. In another study qRT PCR is used to validate microarray studies. In this work, gene expression 
profiles of rat cerebellum were evaluated in response to mixtures of methylmercury, polychlorinated 
biphenyls and organochlorine pesticides. This technique revealed differential expression in genes that 
regulate key processes in neuronal activity and the authors suggest that these genes are also affected in 
exposed individuals. However, genotyping methods are required since some experiments have 
revealed various genetic polymorphisms that modify effects of chemical exposure in humans. One of 
these methods is TaqMAMA, an RT PCR-based genotyping technique that combines the strengths of 
TaqMan with the allelic discrimination of the mismatch amplification mutation assay (MAMA). Int. J. Mol. Sci. 2010, 11                 
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A recent report uses qRT PCR to measure gene expression of human kidney cells exposed to uranium. 
In this paper, the level of the SPP1 gene is greatly increased and the author suggests its use as a 
biomarker to evaluate occupational exposure [28,29].  
3.2. ELISA 
The ELISA technique is appropriate for the general assessment of immune, metabolic and 
genotoxic responses resulting from chemical exposure. This technique is highly sensitive and can be 
quantitative. Nowadays, because of the wide variety of commercial kits, the assay can be easily 
incorporated into industrial drug and chemical efficacy testing programs. Some of these kits are useful 
to measure metabolites as a result of chemical exposure. For instance, exposure to tobacco smoke can 
be detected by measuring nicotine and its metabolite cotinine. Due to the long half-life, cotinine has 
been considered to be a reliable biomarker for smoking status and several suppliers have ELISA kits 
that detect and measure cotinine levels. In other cases, ELISA kits are used to measure protein levels 
serving as biomarkers. Upon investigation, some proteins involved in the inflammatory response, 
specifically lipoxygenase and leukotriene, increase their expression with exposure to arsenic [30]. 
Another common use of ELISA in evaluation of chemical exposure effects is to determine induced 
cellular damage. By using ELISA, the levels of proteins involved in apoptosis or cell viability can be 
measured [31]. A recent study suggests that ELISA may be a valuable tool for evaluating cytokine 
levels in workers exposed to organic dust [32]. In another study ELISA was used to measure diverse 
cytokine levels in response to isocyanates (a group of low molecular weight aromatic and aliphatic 
compounds with diverse industrial applications) in isolated lymphocytes from volunteers [33]. In both 
studies cytokine levels were found to increase, suggesting that chemical exposure has important 
immunotoxic consequences. Finally, the ELISA technique has been applied to detect adducts between 
chemicals and biologic molecules such as DNA or proteins [34,35]. 
3.3. Microarrays 
Recently, the use of microarrays has found several applications in chemical exposure evaluations, 
making the application of gene expression analysis in toxicology a mature science. Although this 
technology remains expensive, the field has rapidly progressed and gene expression profiling is now 
being used in screening for toxicity of new and existing chemical compounds and their effects on 
organisms [36]. Sen, Mahadevan and DeMarini (2007) did an excellent review of the analysis of gene 
expression in the presence of complex mixtures (cigarette smoke, urban air or diesel exhaust particles) 
and common contaminants. They found that complex mixtures generally induced expression of genes 
involved in oxidative stress response and xenobiotic metabolism [37]. They observed the expression of 
two genes, heme oxygenase 1 and CYP1A1, to be induced by each of the complex mixtures texted. For 
instance, in a recent study microarray technology was used to analyze gene expression of alveolar cells 
exposed to diesel particle extract. This work revealed multiple up-regulated genes involved in 
metabolism, cell cycle, apoptosis and antioxidant activities, among others [38]. In another study, the 
use of microarray analysis from the global gene expression profile of rat blood identified distinct gene 
expression markers capable of detecting and distinguishing if hepatotoxicity and neurotoxicity could 
be induced by different chemical agents [39]. Another common occupational health hazard is exposure Int. J. Mol. Sci. 2010, 11                 
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to radiation. Microarray technology has been used to investigate its effect by analyzing gene 
expression profiles of lymphocytes isolated from radiation exposed-workers. Gene expression analysis 
revealed statistically significant transcriptional changes in a total of 78 genes (21 up-regulated and 
57 down-regulated) involved in several biological processes including DNA repair, cell proliferation 
and stress response [40]. Finally, microarray technology was used to observe that exposure to 
polycyclic aromatic hydrocarbons in HepG2 and A549 cells altered several important pathways and 
genes including xenobiotic metabolism, oxidative stress response, proliferation, protein degradation 
and ion transportation, among others [41]. 
4. “Omics” in Analysis of Chemical Exposure 
This new molecular approach to studying gene-environment interactions is referred to as 
toxicogenomics. It combines genomics, transcriptomics, proteomics, metabolomics and bioinformatics 
with conventional toxicology and pathology to analyze effects of occupational exposure on thousands 
of genes and proteins simultaneously. The creation of databanks and the development of new methods 
to analyze multiple genes or products simultaneously represent a multitude of new opportunities in 
toxicological studies and occupational health.  
4.1. Genomics and Transcriptomics 
At the forefront of these emerging technologies is the use of functional genomics or analysis of 
molecular perturbations to be assayed by microarray technology. Genomic biomarkers of toxicity have 
recently been identified for a wide variety of toxicants including nephrotoxic agents, testicular 
toxicants, and for keratinocyte proliferation in a papilloma murine skin model. Microarrays have also 
enabled high-throughput screening (HTS; a method that allows the rapid performance of millions of 
biochemical, genetic or pharmacological tests) of chemicals for potential toxicity. Increased sensitivity 
to detect molecular signatures or “fingerprints” is associated with a particular class of chemicals or 
toxic responses in both in vitro and in vivo systems [42]. Benzene, a potentially noxious substance, is a 
common solvent used in the manufacturing industry. The availability of biomarkers to detect benzene 
exposure has increased by using gene profiling “omics” techniques. The analysis of peripheral blood 
cells from benzene exposed workers revealed that more than 100 genes have differentially altered 
expressions [43].  
4.2. Proteomics 
The applications of proteomics in toxicology and analysis of chemical exposure can be divided into 
two classes: investigative studies, and screening or predictive toxicology. Investigative studies may 
help to identify new molecular targets for toxins and provide novel clues into mechanisms of action. 
Predictive toxicology refers to the screening of novel compounds and the study of structure-activity 
relationships (SARs) within a group. The use of proteomics in screening and predictive toxicology has 
two principal applications: establishing relationships between toxic effects and defining protein 
molecular biomarkers, i.e., identifying toxicological biomarkers, and recognition of specific response 
patterns. Completely mapped proteomes of important biological fluids, such as blood serum or urine, Int. J. Mol. Sci. 2010, 11                 
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will be crucial for biomarker development. Furthermore, identification of specific xenobiotic-protein 
adducts by proteomics will provide insights in immune, cellular and molecular responses to toxicants. 
The focus of proteomics ranges from global protein analysis to a more specific level of protein analysis. 
Some of the more common techniques used in proteomics include 2D gel analysis, mass spectrometry 
and chromatography. For instance, a recent study evaluates the proteomic profile of urine from 
uranium-exposed rats. Uranium is used in several industries and is a well known nephrotoxin. In 
normal urine there are, at least, 102 proteins; expression of fourteen of these proteins was significantly 
different in treated rats [44]. Another example is the proteomic analysis of ovaries from rats exposed to 
tetrachlorodibenzo-p-dioxin (TCDD). TCDD is a dioxin-derivative found at low concentrations in 
industrial wastewater. This compound induces an endocrine disruption that affects the reproductive 
system. In this study, the matrix-assisted laser desorption/ionization (MALDI) tandem mass 
spectrometry showed distinct changes in the levels of several proteins that are relevant markers for 
TCDD toxicity [45]. Proteomics is also useful to evaluate protein profiles from cell cultures. In a 
recent paper, epithelial cells were treated with trans,trans-2,4-decadienal (tt-DDE), a specific type of 
dienaldehyde that is abundant in heated oils or cooking oil fumes. Proteomic analysis by 2D 
electrophoresis and mass spectrometry revealed that two proteins DJ-1 (an oncogenic protein 
responsive to oxidative stress) and cofilin (a member of the actin depolymerization factor 
(ADF)/cofilin family and essential protein for cell viability) are suitable biomarkers for tt-DDE 
exposure [46]. 
4.3. Metabolomics 
Metabolite prediction is based on a reaction-mechanism-based methodology, which applies 
fundamental organic and enzyme chemistry. This tool can be used to complement experimental studies 
of chemical mixtures, aid in risk assessment and help to understand the effects of complex chemical 
mixtures. Chemical agents at low dose levels can produce biological responses in protein expression 
patterns (proteomic responses) or alterations in sensitive metabolic pathways (metabolomic responses). 
Metabolomics is advantageous because (a) it analyses the last step in a series of changes following a 
toxic insult; (b) many metabolites have a known function and (c) changes are detectable in blood. 
Recently, a study revealed that metabolic profiles from butylbenzyl phthalate (BBP) treated-rats 
exhibited different patterns in comparison to non-treated individuals. Worker exposure to BBP was 
estimated at 143 and 286 μg kg
−1 body weight per day by recovering metabolites from urine and 
considered for differences in dose, vehicle and sex. The authors suggested that the application of 
metabolomics was useful to understand the mechanistic link between low levels of environmental or 
occupational exposure and disease/dysfunction in a human population. Moreover, the use of biological 
fluids such as urine simplifies sample processing and analysis [47]. The complete integration of 
several study branches is called systems toxicology [48] of which the final aim is to improve human 
health using and complementing data obtained from individual disciplines. 
5. Bioinformatics 
Computational or in silico, analyses lend substantial predictive power to evaluate occupational risk 
in addition to traditional methods of experimental biology. In this way, bioinformatics has become a Int. J. Mol. Sci. 2010, 11                 
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powerful tool in toxicological research. Moreover, bioinformatics allows creation and administration 
of large gene or protein databanks. Methods of data integration for orthogonal “omics” datasets fall 
broadly into two categories: (a) biology-driven strategies and (b) data-driven strategies. Biological 
interpretations tend to be more hypothesis-driven and take advantage of a contextual understanding of 
what is currently known about the toxicity mechanism [42]. Some toxicants can be preferentially 
targeted to specific organs, tissues, or cell types due to their affinity for target proteins, often expressed 
in a tissue-specific manner or expressed at higher levels in the target tissue. The expression of these 
proteins and their mRNAs has traditionally been examined experimentally using immunological, 
hybridization, or PCR-based detection methods. However, with the advent of expressed sequence tags 
(ESTs) it is now possible to qualitatively and quantitatively measure mRNAs of target genes in a tissue 
and stage-specific manner by searching and counting ESTs in public databases. The development of 
software to analyze gene clusters is another powerful technique. SAMURAI is a program which 
organizes gene clusters from a library and complements the information with a chemical toxicity 
dataset, allowing for the assessment of the up/down-regulation of gene sets [49]. Another example of 
integrative bioinformatics is the Chemical Effects in Biological Systems (CEBS) [50], the integration 
of a DNA microarray, including proteomic and metabolomic studies, with toxicology data and the 
queries across “omic” platforms that generate new potential biomarkers of exposure (Figure 2).   
A recent study reports the development of a program called ebTrack. This bioinformatic tool integrates 
several databases and predictive tools that are critical for environmental and occupational health 
research. These health risk analysis tools include the Modeling ENvironment for TOtal Risk studies 
(MENTOR) for source-to-dose exposure modeling and the DOse Response Information ANalysis 
system (DORIAN) for health outcome modeling [51]. Another popular database is the   
comparative toxicogenomics database (CTD) which helps to understand the chemical-gene-disease 
relationship [52,53]. Profiles of chemical effects on cells (pCEC) is a recent database which offers a 
new tool to evaluate risk [54]. This tool is able to manage data from DNA microarrays, proteomics or 
metabolomics and integrate this data with models based for the “coupled” toxicokinetics and 
toxicodynamics of contaminants of concern and their mixtures. These tools make the search for 
potential biomarkers in occupational health easier and faster. 
6. Molecular Biology in Evaluation of Risk to Chemical Exposure 
Risk assessment focuses on maintaining exposure to environmental agents below the level at which 
significant perturbations of these pathways occur. The most important exposure assessment is the 
biologically effective dose, which is, the dose available at the site of the target tissue in the body. The 
biologically effective dose can typically be measured as the intact chemical or a biomolecular adduct 
in the target tissue. Blood and urine are, by far the most common matrices. Human Biomonitoring 
(HBM) can be done for most chemical substances and is currently a focus of the worldwide discussion 
of environmental medicine. This procedure has a particularly effective for monitoring metals, PAHs, 
phthalates, dioxins, pesticides, as well as for aromatic amines, perfluorinated chemicals, environmental 
tobacco smoke and volatile organic compounds. Determination of protein adducts (especially   
Hb-adducts) or DNA adducts are still better means to estimate cancer risk than measuring genotoxic 
substances and their metabolites in the human body fluids [55]. HBM measurements have been long Int. J. Mol. Sci. 2010, 11                 
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used for evaluating occupational exposure to a variety of industrial chemicals. Molecular biology 
techniques are therefore a valuable tool for measuring chemical exposure. 
Figure 2. Development of new biomarkers to evaluate chemical effects in biological 
systems. An integrative approach using molecular biology tools include results from 
microarrays, proteomic analysis, metabolomics, and gene expression that will be useful to 
create databanks and develop new biomarkers of exposure. Adapted from   
Wetmore (2004) [50]. 
 
6.1. Polycyclic Aromatic Compounds 
Human exposure to PAHs can occur via inhalation, skin deposition/contamination or orally. 
Biomonitoring in the work environment is usually conducted using urine and blood samples. PAHs 
can be oxidized to electrophilic compounds that can react with macromolecules such as DNA or 
proteins to give adducts. Detection of these adducts is an important tool to evaluate risk as well as the 
level and degree of chemical exposure to PAHs. DNA adducts are considered biomarkers of effect in a 
specific target organ. Other common biomarkers to PAHs exposure are chromosomal aberrations 
(CA), micronuclei (MN) and mutations which are indicative of irreversible effects. The main human 
exposure groups to PAHs are workers from the coal, oil, asphalt or aluminum industries along with 
individuals exposed to everyday environments [56]. Int. J. Mol. Sci. 2010, 11                 
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6.2. Metals and Non-Metals 
These materials represent an important source of dangerous exposure in humans, particularly in 
chemical industry workers. Metals, such as iron, lead, cadmium, chromium or non-metals such as 
arsenic and asbestos are some of the most commonly used raw materials in industry. Although the 
immediate and long-term effects of continuous exposure to these materials are widely known a recent 
review describes new developments in cadmium (Cd) exposure analysis [57]. Some biomarkers to 
detect Cd include albumin, beta-2 microglobulin, retinol binding protein and glucosamine-6-phosphate 
deaminase (NAG/NAGB). However, Cd causes damage in several organs and tissues. For this reason 
new biomarkers and molecular techniques to detect metals are needed. It is commonly known that 
exposure to metals reduce lymphocyte levels. Metals and metal compounds responsible for reduced 
circulating antibody titers are lead, cadmium, methylmercury, arsenic, nickel, chromium and   
platinum [58]. Analysis of antibody titer is a suitable assay to measure chemical exposure. 
6.3. Radiactive Materials 
Nuclear industry workers and health personnel that use radioactive material in addition to people 
exposed accidentally to radiation need biomonitoring to measure their level of exposure. Chromosome 
aberration analysis is the conventional mean for assessing radiation exposure. A recent report suggests 
the real-time fluorogenic 5'-nuclease, or TaqMan polymerase chain reaction assay is being used to 
identify radiation-responsive molecular biomarkers, including gene expression targets and DNA 
mutations [59]. 
7. Conclusions  
Exposure to harmful substances can be expected in several areas of work and there is a causal 
connection between work-related exposure and disease. There are two measurement strategies in 
environmental and occupational medicine to record the health risk to the general population and to 
exposed employees: environmental monitoring and biomonitoring. Although environmental 
monitoring has been used extensively, biomonitoring is a relatively new way of recording and 
quantifying environmental and occupational loads. The selection of the biomonitoring parameter for 
each case must be based on the specific toxic effect of the foreign substance. Biomonitoring studies 
cover workers from countries worldwide and from various industries including: oil, coal mines, 
agriculture, etc., and for different markers and noxious compounds. Literature on the biomonitoring of 
specific populations is growing and through molecular biology tools this process is now much faster 
and more accurate. Molecular biology techniques have become useful and powerful tools in 
occupational disease and chemical exposures studies. The greatest contributions thus far have involved 
understanding mechanisms and modes of action. 
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